Combination of Quercetin or/and siRNA-loaded DDAB-mPEG-PCL hybrid nanoparticles reverse resistance to Regorafenib in colon cancer cells

Colorectal cancer (CRC) is the second leading cause of cancer death. Although Regorafenib showed survival benefits in patients with CRC, reports imply the recurrence of malignant phenotype resulting from chemo...

Source: BMC Complementary and Alternative Medicine - December 27, 2022 Category: Complementary Medicine Authors: Shabnam Shahidi, Kobra Rostamizadeh, Mojtaba Fathi, Keivan Nedaei and Ali Ramazani Tags: Research Source Type: research